Psychiatry and Mental Health - Global Neurology Academy

17-32 of 96

Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
- Jeffrey A. Lieberman, MD
Identifying and Managing Violence Risk in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of Schizophrenia
Identifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Digital Danger: Understanding AI Psychosis in Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiers
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Charles Turck, PharmD, BCPS, BCCCP; Desiree Matthews, PMHNP-BC
- Charles Turck, PharmD, BCPS, BCCCP
- Desiree Matthews, PMHNP-BC
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiers
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Shelina Ramnarine, PhD; Michelle Scargle, MD
- Shelina Ramnarine, PhD
- Michelle Scargle, MD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiers
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Charles Turck, PharmD, BCPS, BCCCP; Ragy R. Girgis, MD, MS
- Charles Turck, PharmD, BCPS, BCCCP
- Ragy R. Girgis, MD, MS
- Desiree Matthews, PMHNP-BC
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of Schizophrenia
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Brian P. McDonough, MD, FAAFP; Ahmed Makhlouf, MD
- Brian P. McDonough, MD, FAAFP
- Ahmed Makhlouf, MD
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiers
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Charles Turck, PharmD, BCPS, BCCCP; David Kimhy, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- David Kimhy, PhD
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiers
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Shelina Ramnarine, PhD; Apurva Bhatt, MD
- Shelina Ramnarine, PhD
- Apurva Bhatt, MD
- Shannon Pagdon, BA
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiers
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
Jeffrey A. Lieberman, MD
- Jeffrey A. Lieberman, MD
Harnessing AI to Predict and Prevent Schizophrenia Relapse
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiers
Harnessing AI to Predict and Prevent Schizophrenia Relapse
Matcheri S. Keshavan, MD
- Matcheri S. Keshavan, MD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD; Jonathan M. Meyer
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
From Resistance to Response: Evolving Strategies in MDD Management
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
Joseph F. Goldberg, MD
1.00 credit
- Joseph F. Goldberg, MD
1.00 credit
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiers
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
MinuteCE®
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Raman Sankar, MD, PhD; Scott Aaronson, MD
0.50 program credits
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 program credits
VNS: Beyond Seizure Control
VNS: Beyond Seizure Control
MinuteCE®
VNS: Beyond Seizure Control
Raman Sankar, MD, PhD; Scott Aaronson, MD
0.50 program credits
- Raman Sankar, MD, PhD
- Scott Aaronson, MD
0.50 program credits

2/6